Commonwealth Equity Services
TSHA icon

Commonwealth Equity Services’s Taysha Gene Therapies TSHA Stock Holding History

Commonwealth Equity Services’s Portfolio TSHA Stock Details TSHA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$421K Buy
61,773
+3,331
+6% +$19.7K ﹤0.01% 3451
2026
Q1 		$261K Buy
58,442
+2,785
+5% +$12.9K ﹤0.01% 3752
2025
Q4 		$306K Sell
55,657
-2,600
-4% -$12.6K ﹤0.01% 3635
2025
Q3 		$191K Sell
58,257
-1,779
-3% -$5.04K ﹤0.01% 3961
2025
Q2 		$139K Sell
60,036
-33
-0.1% -$72 ﹤0.01% 4005
2025
Q1 		$83K Buy
60,069
+1,000
+2% +$1.67K ﹤0.01% 4014
2024
Q4 		$102K Buy
59,069
+31,000
+110% +$64.3K ﹤0.01% 3903
2024
Q3 		$56K Buy
28,069
+800
+3% +$1.75K ﹤0.01% 3923
2024
Q2 		$61K Hold
27,269
– – ﹤0.01% 3875
2024
Q1 		$78K Buy
27,269
+500
+2% +$1.04K ﹤0.01% 3841
2023
Q4 		$47K Sell
26,769
-202
-0.7% -$403 ﹤0.01% 3764
2023
Q3 		$85K Buy
26,971
+8,246
+44% +$15.4K ﹤0.01% 3592
2023
Q2 		$12K Hold
18,725
– – ﹤0.01% 3779
2023
Q1 		$14K Buy
18,725
+5,000
+36% +$6.46K ﹤0.01% 3701
2022
Q4 		$31K Buy
+13,725
New +$27.8K ﹤0.01% 3564

Other funds holding TSHA

Avoro Capital Advisors
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
RA Capital Management
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vestal Point Capital
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
RTW Investments
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Commonwealth Equity Services's TSHA Position: Q2 2026 in Review

Commonwealth Equity Services increased its Taysha Gene Therapies (TSHA) stake by 5.7% in Q2 2026, buying an estimated $19.7K and bringing the position to 61,773 shares worth $421K. The position accounts for ﹤0.01% of the portfolio, ranked #3451.

Commonwealth Equity Services first reported a position in TSHA in Q4 2022 and has held it in 15 quarters since. 208 funds tracked by Wall St. Rank hold TSHA as of Q2 2026.

  • Commonwealth Equity Services held 61,773 shares of Taysha Gene Therapies worth $421K as of Q2 2026.
  • Commonwealth Equity Services bought 3,331 Taysha Gene Therapies shares in Q2 2026, an estimated $19.7K.
  • Taysha Gene Therapies made up ﹤0.01% of Commonwealth Equity Services's portfolio in Q2 2026, its #3451 holding.
  • Commonwealth Equity Services first reported a position in Taysha Gene Therapies in Q4 2022 and has held it in 15 quarters since.
  • 208 funds tracked by Wall St. Rank held Taysha Gene Therapies as of Q2 2026.

Based on Commonwealth Equity Services's 13F filing for Q2 2026, filed 29 Jul 2026.